JNJ
190.6
-0.77%↓
ABT
126.77
+0.33%↑
MDT
93.77
-0.45%↓
VEEV
293.21
+0.68%↑
A
148.21
+0.39%↑
JNJ
190.6
-0.77%↓
ABT
126.77
+0.33%↑
MDT
93.77
-0.45%↓
VEEV
293.21
+0.68%↑
A
148.21
+0.39%↑
JNJ
190.6
-0.77%↓
ABT
126.77
+0.33%↑
MDT
93.77
-0.45%↓
VEEV
293.21
+0.68%↑
A
148.21
+0.39%↑
JNJ
190.6
-0.77%↓
ABT
126.77
+0.33%↑
MDT
93.77
-0.45%↓
VEEV
293.21
+0.68%↑
A
148.21
+0.39%↑
JNJ
190.6
-0.77%↓
ABT
126.77
+0.33%↑
MDT
93.77
-0.45%↓
VEEV
293.21
+0.68%↑
A
148.21
+0.39%↑
24h
Corrente
Minimo
2.52
Massimo
2.57
Raccomandazioni | Acquista |
|---|---|
Previsioni per 12 mesi | +477.69% upside |
Utili prossimi | 12 nov 2025 |
|---|
Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.
1 ott 2025, 15:07 UTC
Fortress Biotech Shares Drop After FDA Letter for CUTX-101 Manufacturing Facility
DJ
LeggI
10 mar 2025, 02:12 UTC
Checkpoint Controlling Shareholder Fortress Has Agreed to Vote in Favor of Transaction >524715.BY
DJ
LeggI
10 mar 2025, 02:12 UTC
Sun Pharma, Checkpoint Transaction Expected to Complete in 2Q 2025 >524715.BY
DJ
LeggI
10 mar 2025, 02:11 UTC
Sun Pharma, Checkpoint, Fortress Biotech Enter Into Royalty Agreement >524715.BY
DJ
LeggI
10 mar 2025, 02:11 UTC
Checkpoint Shareholders Entitled to Receive Up to Additional $0.70 if Cosibelimab if Approved in EU Prior to Certain Deadlines >524715.BY
DJ
LeggI
10 mar 2025, 02:10 UTC
Checkpoint Shareholders to Receive Upfront Cash Payment of $4.10/Share, Contingent Value Right >524715.BY
DJ
LeggI
10 mar 2025, 02:10 UTC
Sun Pharma to Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
LeggI
10 mar 2025, 02:06 UTC
Sun Pharma To Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
LeggI
Modifica del prezzo
By TipRanks
Previsioni per 12 mesi
Media 14.5 USD 477.69%
Alto 17 USD
Basso 12 USD
Basato su 2 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Fortress Biotech Inc - Dist negli ultimi 3 mesi.
By TipRanks
Acquista
2 ratings
2
Acquista
0
Mantieni
0
Vendi
Basato sugli analisti di 2 che hanno fornito valutazioni azionarie a Fortress Biotech Inc - Dist negli ultimi 3 mesi.
$